Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The document concludes that more research is needed to fully understand the causes of PCOS.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.